Clearance Summary
CARCINOEMBRYONIC ANTIGEN CONTROL (4 LEV received FDA 510(k) clearance under submission number K820298, sponsored by Ventrex Laboratories, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1982-04-08.
- Submission: K820298
- Applicant / Sponsor: Ventrex Laboratories, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.6010
- Decision date: 1982-04-08
Classification & Regulation
This clearance is catalogued under FDA product code DHX and 21 CFR 866.6010, within the Immunology review panel as a Class II device.